Skip to content

3Pharma: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

3Pharma

BE 0647.600.506
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€3
2024 · -€6,072+€6,068
Equity
-€18,557
2024 · -€18,554-€3
Cash
€34,725
2024 · €20,112+€14,613
Balance sheet total
€307,833
2024 · €377,437-€69,603

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€33,368

    down €33,368 (-26.8%), from €124,310 to €90,943

  • Receivables within one year -€32,410

    down €32,410 (-18.1%), from €179,098 to €146,688

    of which Trade receivables: -€29,303

  • Cash +€14,613

    up €14,613 (+72.7%), from €20,112 to €34,725

    mainly Stocks and contracts (+€33,368) and Receivables within one year (+€32,410)

  • Intangible fixed assets -€14,069

    down €14,069 (-29.8%), from €47,219 to €33,150

  • Tangible fixed assets -€4,869

    down €4,869 (-81.7%), from €5,959 to €1,089

    of which Furniture and vehicles: -€4,067

Equity and liabilities
  • Trade debts -€29,864

    down €29,864 (-11.1%), from €269,041 to €239,178

  • Debts after one year -€18,628

    down €18,628 (-29.7%), from €62,779 to €44,151

  • Tax, wage and social debts -€13,388

    down €13,388 (-39.3%), from €34,107 to €20,719

    of which Remuneration and social security: -€9,595

  • Other debts -€5,822

    down €5,822 (-61.0%), from €9,537 to €3,715

Income statement
  • Staff costs -€42,807

    down €42,807 (-45.0%), from €95,041 to €52,234

  • Gross operating margin -€30,302

    down €30,302 (-26.4%), from €114,639 to €84,337

  • Depreciation +€4,532

    up €4,532 (+31.5%), from €14,407 to €18,939

  • Other operating charges +€1,546

    up €1,546 (+44.8%), from €3,454 to €5,001

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€6,072
Gross operating margin -€30,302
Staff costs +€42,807
Depreciation -€4,532
Write-downs -€65
Other operating charges -€1,546
Other operating items -€2,103
Financial income +€699
Financial charges +€1,110
Result 2025 -€3

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€35,139
Investment €0
Financing -€20,526
Cash 2024 €20,112
Net result for the year -€3
Depreciation +€18,939
Stocks and contracts +€33,368
Receivables within one year +€32,410
Deferred charges and accrued income -€499
Trade debts -€29,864
Tax, wage and social debts -€13,388
Other debts -€5,822
Debts after one year -€18,628
Current portion of long-term debt -€1,899
Cash 2025 €34,725
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €377,437 €307,833 -€69,603 -18.4%
Fixed assets 21/28 €53,178 €34,239 -€18,939 -35.6%
Intangible fixed assets 21 €47,219 €33,150 -€14,069 -29.8%
Tangible fixed assets 22/27 €5,959 €1,089 -€4,869 -81.7%
Plant, machinery and equipment 23 €803 €0 -€803 -100.0%
Furniture and vehicles 24 €5,156 €1,089 -€4,067 -78.9%
Other tangible fixed assets 26 €0 - =
Current assets 29/58 €324,259 €273,594 -€50,665 -15.6%
Stocks and contracts in progress 3 €124,310 €90,943 -€33,368 -26.8%
Stocks 30/36 €124,310 €90,943 -€33,368 -26.8%
Amounts receivable within one year 40/41 €179,098 €146,688 -€32,410 -18.1%
Trade receivables 40 €163,655 €134,352 -€29,303 -17.9%
Other amounts receivable 41 €15,443 €12,336 -€3,107 -20.1%
Cash at bank and in hand 54/58 €20,112 €34,725 +€14,613 +72.7%
Deferred charges and accrued income 490/1 €739 €1,238 +€499 +67.6%
Total equity and liabilities 10/49 €377,437 €307,833 -€69,603 -18.4%
Equity 10/15 -€18,554 -€18,557 -€3 0.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €178 €178 = 0.0%
Non-distributable reserves 130/1 €178 €178 = 0.0%
Reserves not available under the articles 1311 €178 €178 = 0.0%
Profit (loss) carried forward 14 -€37,332 -€37,335 -€3 0.0%
Amounts payable 17/49 €395,990 €326,391 -€69,600 -17.6%
Amounts payable after more than one year 17 €62,779 €44,151 -€18,628 -29.7%
Financial debts 170/4 €62,779 €44,151 -€18,628 -29.7%
Amounts payable within one year 42/48 €333,212 €282,239 -€50,972 -15.3%
Current portion of amounts payable after more than one year 42 €20,526 €18,628 -€1,899 -9.2%
Trade debts 44 €269,041 €239,178 -€29,864 -11.1%
Suppliers 440/4 €269,041 €239,178 -€29,864 -11.1%
Taxes, remuneration and social security 45 €34,107 €20,719 -€13,388 -39.3%
Taxes 450/3 €14,150 €10,358 -€3,792 -26.8%
Remuneration and social security 454/9 €19,957 €10,362 -€9,595 -48.1%
Other amounts payable 47/48 €9,537 €3,715 -€5,822 -61.0%
Non-recurring operating income 76A €1,565 €3,384 +€1,820 +116.3%
Remuneration, social security and pensions 62 €95,041 €52,234 -€42,807 -45.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €14,407 €18,939 +€4,532 +31.5%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €3,704 €3,768 +€65 +1.7%
Other operating charges 640/8 €3,454 €5,001 +€1,546 +44.8%
Non-recurring operating charges 66A €13 €2,116 +€2,103 +15990.3%
Gross operating margin 9900 €114,639 €84,337 -€30,302 -26.4%
Operating profit (loss) 9901 -€1,980 €2,280 +€4,260
Financial income 75/76B €768 €1,466 +€699 +91.0%
Recurring financial income 75 €768 €1,466 +€699 +91.0%
Financial charges 65/66B €4,860 €3,750 -€1,110 -22.8%
Recurring financial charges 65 €4,860 €3,750 -€1,110 -22.8%
Profit (loss) for the period before taxes 9903 -€6,072 -€3 +€6,068 +99.9%
Profit (loss) for the period 9904 -€6,072 -€3 +€6,068 +99.9%
Profit (loss) for the period to be appropriated 9905 -€6,072 -€3 +€6,068 +99.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.